{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T17:33:08Z","timestamp":1780507988882,"version":"3.54.1"},"reference-count":37,"publisher":"Oxford University Press (OUP)","issue":"suppl_5","license":[{"start":{"date-parts":[[2018,6,25]],"date-time":"2018-06-25T00:00:00Z","timestamp":1529884800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Instituto de Investigaci\u00f3n Carlos III","award":["PI 1400708"],"award-info":[{"award-number":["PI 1400708"]}]},{"name":"Instituto de Investigaci\u00f3n Carlos III","award":["1500171"],"award-info":[{"award-number":["1500171"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,11,22]]},"DOI":"10.1093\/infdis\/jiy302","type":"journal-article","created":{"date-parts":[[2018,5,23]],"date-time":"2018-05-23T07:07:06Z","timestamp":1527059226000},"page":"S574-S581","source":"Crossref","is-referenced-by-count":14,"title":["Broad Neutralizing Activity Against Ebolaviruses Lacking the Mucin-Like Domain in Convalescent Plasma Specimens From Patients With Ebola Virus Disease"],"prefix":"10.1093","volume":"218","author":[{"given":"Joanna","family":"Luczkowiak","sequence":"first","affiliation":[{"name":"Department of Microbiology, Instituto de Investigaci\u00f3n Hospital 12 de Octubre, Hospital Universitario 12 de Octubre, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatima","family":"Lasala","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Instituto de Investigaci\u00f3n Hospital 12 de Octubre, Hospital Universitario 12 de Octubre, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2735-5931","authenticated-orcid":false,"given":"Marta","family":"Mora-Rillo","sequence":"additional","affiliation":[{"name":"Infectious Diseases Unit, Department of Internal Medicine, Instituto de Investigaci\u00f3n Hospital La Paz, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose R","family":"Arribas","sequence":"additional","affiliation":[{"name":"Infectious Diseases Unit, Department of Internal Medicine, Instituto de Investigaci\u00f3n Hospital La Paz, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6912-4736","authenticated-orcid":false,"given":"Rafael","family":"Delgado","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Instituto de Investigaci\u00f3n Hospital 12 de Octubre, Hospital Universitario 12 de Octubre, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,6,25]]},"reference":[{"key":"key\n\t\t\t\t2018112203574366400_CIT0001","first-page":"141","article-title":"Ebola virus disease in humans: pathophysiology and immunity","volume":"411","author":"Mu\u00f1oz-Fontela","year":"2017","journal-title":"Curr Top Microbiol Immunol"},{"key":"key\n\t\t\t\t2018112203574366400_CIT0002","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1056\/NEJMsr1513109","article-title":"After Ebola in West Africa \u2014 unpredictable risks, preventable epidemics","volume":"375","author":"Team","year":"2016","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2018112203574366400_CIT0003","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/nature10380","article-title":"Small molecule inhibitors reveal Niemann-Pick C1 is essential for Ebola virus infection","volume":"477","author":"C\u00f4t\u00e9","year":"2011","journal-title":"Nature"},{"key":"key\n\t\t\t\t2018112203574366400_CIT0004","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/nature10348","article-title":"Ebola virus entry requires the cholesterol transporter Niemann-Pick C1","volume":"477","author":"Carette","year":"2011","journal-title":"Nature"},{"key":"key\n\t\t\t\t2018112203574366400_CIT0005","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1126\/science.1110656","article-title":"Endosomal proteolysis of the Ebola virus glycoprotein is necessary for infection","volume":"308","author":"Chandran","year":"2005","journal-title":"Science"},{"key":"key\n\t\t\t\t2018112203574366400_CIT0006","doi-asserted-by":"crossref","first-page":"4174","DOI":"10.1128\/JVI.80.8.4174-4178.2006","article-title":"Role of endosomal cathepsins in entry mediated by the Ebola virus glycoprotein","volume":"80","author":"Schornberg","year":"2006","journal-title":"J Virol"},{"key":"key\n\t\t\t\t2018112203574366400_CIT0007","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.1128\/JVI.01956-08","article-title":"The primed ebolavirus glycoprotein (19-kilodalton GP1,2): sequence and residues critical for host cell binding","volume":"83","author":"Dube","year":"2009","journal-title":"J Virol"},{"key":"key\n\t\t\t\t2018112203574366400_CIT0008","doi-asserted-by":"crossref","first-page":"S825","DOI":"10.1093\/infdis\/jir295","article-title":"Impact of Ebola mucin-like domain on antiglycoprotein antibody responses induced by Ebola virus-like particles","volume":"204","author":"Martinez","year":"2011","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t2018112203574366400_CIT0009","doi-asserted-by":"crossref","first-page":"17182","DOI":"10.1073\/pnas.1414164111","article-title":"Structures of protective antibodies reveal sites of vulnerability on Ebola virus","volume":"111","author":"Murin","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key\n\t\t\t\t2018112203574366400_CIT0010","doi-asserted-by":"crossref","first-page":"20514","DOI":"10.1038\/srep20514","article-title":"Discovery of an antibody for pan-ebolavirus therapy","volume":"6","author":"Furuyama","year":"2016","journal-title":"Sci Rep"},{"key":"key\n\t\t\t\t2018112203574366400_CIT0011","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1126\/science.aad5788","article-title":"Isolation of potent neutralizing antibodies from a survivor of the 2014 Ebola virus outbreak","volume":"351","author":"Bornholdt","year":"2016","journal-title":"Science"},{"key":"key\n\t\t\t\t2018112203574366400_CIT0012","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1016\/j.celrep.2016.04.026","article-title":"Antibody treatment of ebola and sudan virus infection via a uniquely exposed epitope within the glycoprotein receptor-binding site","volume":"15","author":"Howell","year":"2016","journal-title":"Cell Rep"},{"key":"key\n\t\t\t\t2018112203574366400_CIT0013","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.cell.2015.12.022","article-title":"Cross-reactive and potent neutralizing antibody responses in human survivors of natural Ebolavirus infection","volume":"164","author":"Flyak","year":"2016","journal-title":"Cell"},{"key":"key\n\t\t\t\t2018112203574366400_CIT0014","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.cell.2017.04.038","article-title":"Immunization-elicited broadly protective antibody reveals ebolavirus fusion loop as a site of vulnerability","volume":"169","author":"Zhao","year":"2017","journal-title":"Cell"},{"key":"key\n\t\t\t\t2018112203574366400_CIT0015","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.cell.2017.04.037","article-title":"Antibodies from a human survivor define sites of vulnerability for broad protection against ebolaviruses","volume":"169","author":"Wec","year":"2017","journal-title":"Cell"},{"key":"key\n\t\t\t\t2018112203574366400_CIT0016","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.virusres.2015.12.019","article-title":"Specific neutralizing response in plasma from convalescent patients of Ebola virus disease against the West Africa Makona variant of Ebola virus","volume":"213","author":"Luczkowiak","year":"2016","journal-title":"Virus Res"},{"key":"key\n\t\t\t\t2018112203574366400_CIT0017","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/S2213-2600(15)00180-0","article-title":"Acute respiratory distress syndrome after convalescent plasma use: treatment of a patient with Ebola virus disease contracted in Madrid, Spain","volume":"3","author":"Mora-Rillo","year":"2015","journal-title":"Lancet Respir Med"},{"key":"key\n\t\t\t\t2018112203574366400_CIT0018","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1006\/viro.1995.1016","article-title":"Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes","volume":"206","author":"Connor","year":"1995","journal-title":"Virology"},{"key":"key\n\t\t\t\t2018112203574366400_CIT0019","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1126\/science.1259657","article-title":"Genomic surveillance elucidates Ebola virus origin and transmission during the 2014 outbreak","volume":"345","author":"Gire","year":"2014","journal-title":"Science"},{"key":"key\n\t\t\t\t2018112203574366400_CIT0020","doi-asserted-by":"crossref","first-page":"4760","DOI":"10.3390\/v6114760","article-title":"Nomenclature- and database-compatible names for the two Ebola virus variants that emerged in Guinea and the Democratic Republic of the Congo in 2014","volume":"6","author":"Kuhn","year":"2014","journal-title":"Viruses"},{"key":"key\n\t\t\t\t2018112203574366400_CIT0021","doi-asserted-by":"crossref","first-page":"13378","DOI":"10.1128\/JVI.01170-07","article-title":"Proteolysis of the Ebola virus glycoproteins enhances virus binding and infectivity","volume":"81","author":"Kaletsky","year":"2007","journal-title":"J Virol"},{"key":"key\n\t\t\t\t2018112203574366400_CIT0022","doi-asserted-by":"crossref","first-page":"12463","DOI":"10.1128\/JVI.76.24.12463-12472.2002","article-title":"Covalent modifications of the ebola virus glycoprotein","volume":"76","author":"Jeffers","year":"2002","journal-title":"J Virol"},{"key":"key\n\t\t\t\t2018112203574366400_CIT0023","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1093\/cid\/civ680","article-title":"The use of Ebola convalescent plasma to treat Ebola virus disease in resource-constrained settings: a perspective from the field","volume":"62","author":"van Griensven","year":"2016","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t2018112203574366400_CIT0024","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1093\/infdis\/jiw333","article-title":"Passive immunotherapy: assessment of convalescent serum against Ebola virus makona infection in nonhuman primates","volume":"214","author":"Mire","year":"2016","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t2018112203574366400_CIT0025","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.virol.2015.03.030","article-title":"Innate immune evasion by filoviruses","volume":"479-480","author":"Basler","year":"2015","journal-title":"Virology"},{"key":"key\n\t\t\t\t2018112203574366400_CIT0026","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1126\/science.279.5353.1034","article-title":"Distinct cellular interactions of secreted and transmembrane Ebola virus glycoproteins","volume":"279","author":"Yang","year":"1998","journal-title":"Science"},{"key":"key\n\t\t\t\t2018112203574366400_CIT0027","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1038\/78654","article-title":"Identification of the Ebola virus glycoprotein as the main viral determinant of vascular cell cytotoxicity and injury","volume":"6","author":"Yang","year":"2000","journal-title":"Nat Med"},{"key":"key\n\t\t\t\t2018112203574366400_CIT0028","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1586\/1744666X.2014.908705","article-title":"Characterization of host immune responses in Ebola virus infections","volume":"10","author":"Wong","year":"2014","journal-title":"Expert Rev Clin Immunol"},{"key":"key\n\t\t\t\t2018112203574366400_CIT0029","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/0968-0004(90)90014-3","article-title":"Why are proteins O-glycosylated","volume":"15","author":"Jentoft","year":"1990","journal-title":"Trends Biochem Sci"},{"key":"key\n\t\t\t\t2018112203574366400_CIT0030","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nature01470","article-title":"Antibody neutralization and escape by HIV-1","volume":"422","author":"Wei","year":"2003","journal-title":"Nature"},{"key":"key\n\t\t\t\t2018112203574366400_CIT0031","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1126\/science.287.5458.1664","article-title":"Epitopes involved in antibody-mediated protection from Ebola virus","volume":"287","author":"Wilson","year":"2000","journal-title":"Science"},{"key":"key\n\t\t\t\t2018112203574366400_CIT0032","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.virol.2010.02.029","article-title":"Antibody-mediated neutralization of Ebola virus can occur by two distinct mechanisms","volume":"401","author":"Shedlock","year":"2010","journal-title":"Virology"},{"key":"key\n\t\t\t\t2018112203574366400_CIT0033","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.tim.2016.05.008","article-title":"Feverish quest for Ebola immunotherapy: straight or cocktail","volume":"24","author":"Saphire","year":"2016","journal-title":"Trends Microbiol"},{"key":"key\n\t\t\t\t2018112203574366400_CIT0034","doi-asserted-by":"crossref","first-page":"138ra81","DOI":"10.1126\/scitranslmed.3003876","article-title":"Successful treatment of ebola virus\u2013infected cynomolgus macaques with monoclonal antibodies","volume":"4","author":"Qiu","year":"2012","journal-title":"Sci Transl Med"},{"key":"key\n\t\t\t\t2018112203574366400_CIT0035","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nature13777","article-title":"Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp","volume":"514","author":"Qiu","year":"2014","journal-title":"Nature"},{"key":"key\n\t\t\t\t2018112203574366400_CIT0036","doi-asserted-by":"crossref","first-page":"6305","DOI":"10.1128\/JVI.02545-05","article-title":"The signal peptide of the ebolavirus glycoprotein influences interaction with the cellular lectins DC-SIGN and DC-SIGNR","volume":"80","author":"Marzi","year":"2006","journal-title":"J Virol"},{"key":"key\n\t\t\t\t2018112203574366400_CIT0037","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1086\/382658","article-title":"In vitro evaluation of cyanovirin-N antiviral activity, by use of lentiviral vectors pseudotyped with filovirus envelope glycoproteins","volume":"189","author":"Barrientos","year":"2004","journal-title":"J Infect Dis"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jid\/article-pdf\/218\/suppl_5\/S574\/26689077\/jiy302.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,18]],"date-time":"2019-10-18T06:44:13Z","timestamp":1571381053000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article\/218\/suppl_5\/S574\/5043460"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,25]]},"references-count":37,"journal-issue":{"issue":"suppl_5","published-online":{"date-parts":[[2018,6,25]]},"published-print":{"date-parts":[[2018,11,22]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jiy302","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,12,15]]},"published":{"date-parts":[[2018,6,25]]}}}